Ophthalmology
Update and guidance on management of myopia.
26 Aug, 2021 | 08:35h | UTC
How to wear a mask and not fog up your glasses.
5 Aug, 2021 | 08:56h | UTCHow to wear a mask and not fog up your glasses – The Philadelphia Inquirer
Guideline summary: A Multidisciplinary collaborative approach to retinal toxic effects screening for patients taking antimalarials.
2 Aug, 2021 | 00:03h | UTCA Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials – JAMA Dermatology (free for a limited period)
Original Guidance: Joint Statement: Hydroxychloroquine use with respect to retinal toxicity
Clinical practice guidelines for the medical management of Graves’ orbitopathy.
26 Jul, 2021 | 02:26h | UTC
RCT: Intravitreal ranibizumab vs. aflibercept vs. bevacizumab for macular edema due to central retinal vein occlusion.
15 Jul, 2021 | 09:09h | UTC
Guideline | Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring.
6 Jul, 2021 | 10:03h | UTCExecutive summary: Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring – Royal College of Ophthalmologists
Review: Virtual consultation for red eye.
30 Jun, 2021 | 10:04h | UTCVirtual consultation for red eye – The BMJ
Commentary on Twitter
Red eye is a common ophthalmic presentation in primary care, accounting for 2 to 3% of the consultations.
How can you safely diagnose and manage patients with acute red eye(s) in a virtual consultation?https://t.co/cn12VYpyuW
— The BMJ (@bmj_latest) June 29, 2021
Pragmatic RCT: Among patients with advanced glaucoma, primary trabeculectomy resulted in similar quality of life and safety outcomes and achieved a lower intraocular pressure compared with primary medication.
17 May, 2021 | 08:06h | UTC
Update on Corneal Transplant in 2021
20 Apr, 2021 | 05:33h | UTCUpdate on Corneal Transplant in 2021 – JAMA (free for a limited period)
Study: Teprotumumab for patients with active thyroid eye disease
20 Apr, 2021 | 05:25h | UTCTeprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Study suggests treatment not always needed to prevent vision loss in patients with elevated eye pressure
18 Apr, 2021 | 21:01h | UTCOriginal study: Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up – JAMA Ophthalmology (free for a limited period)
Commentary on Twitter
Only 25% of the OHTS participants developed visual field loss over 20 years of follow-up https://t.co/2DV1gr0cbM
— JAMAOphthalmology (@JAMAOphth) April 15, 2021
AHA Scientific Statement: Management of Central Retinal Artery Occlusion
13 Apr, 2021 | 05:10h | UTCCommentaries: Stroke affecting the eye requires immediate treatment, can signal future vascular events – American Heart Association AND AHA Issues Statement on Central Retinal Artery Occlusion – HealthDay
RCT: Effect of intravitreous anti–vascular endothelial growth factor vs. sham treatment for prevention of vision-threatening complications of diabetic retinopathy
6 Apr, 2021 | 01:02h | UTCCommentaries: Preventive treatment reduces diabetic retinopathy complications – NIH News Releases AND Prevention of Severe Nonproliferative Diabetic Retinopathy Progression With More at Stake Than Visual Acuity – JAMA Ophthalmology AND Practicality of Prophylactic Aflibercept to Reduce Diabetic Retinopathy Progression – JAMA Ophthalmology
Author interview: Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME) – JAMA
Commentary on Twitter
In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, preventive treatment did not confer visual acuity benefit compared with observation plus aflibercept if complications developed https://t.co/q4ABSKOMVj
— JAMAOphthalmology (@JAMAOphth) March 30, 2021
RCT: Efficacy and safety of a dexamethasone intracanalicular insert in patients with allergic conjunctivitis
5 Apr, 2021 | 00:54h | UTCPhase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis – American Journal of Ophthalmology (link to abstract – $ for full-text)
Systematic review: Lens extraction for chronic angle-closure glaucoma
2 Apr, 2021 | 09:01h | UTCLens extraction for chronic angle-closure glaucoma – Cochrane Library
Systematic review: Laser peripheral iridoplasty for chronic angle closure
2 Apr, 2021 | 09:02h | UTCLaser peripheral iridoplasty for chronic angle closure – Cochrane Library
Systematic review: Lens extraction for chronic angle‐closure glaucoma
26 Mar, 2021 | 08:22h | UTCLens extraction for chronic angle‐closure glaucoma – Cochrane Library
Joint Statement: Hydroxychloroquine use with respect to retinal toxicity
28 Feb, 2021 | 20:41h | UTCCommentary: Societies Agree on Eye Safety for HCQ – MedPage Today (free registration required) AND ACR, medical societies reach consensus on hydroxychloroquine retinopathy – Healio (free registration required)
Commentary on Twitter
🆕 Joint statement on #Hydroxychloroquine use with respect to retinal toxicity 👀 by several #rheumatology and #opthtalmology societies. #ocular #toxicity relates to #HCQ dosage and duration of use and is seen in 4.3% to 13.8% of patients 🔎#Lupus #SLEhttps://t.co/ocFSCmgVsN
— Laurent ARNAUD (@Lupusreference) February 18, 2021
Experts worry screen time during Covid-19 could increase vision problems in kids
23 Feb, 2021 | 01:48h | UTCRelated: Progression of myopia in school-aged children after COVID-19 home confinement – JAMA Ophthalmology
The Lancet Commission on Global Eye Health: Vision Beyond 2020
19 Feb, 2021 | 02:38h | UTCGlobal Eye Health: vision beyond 2020 – The Lancet Global Health
Commentary on Twitter
NEW—Eliminating preventable sight loss could bring economic benefits of US$411 billion a year, unlock human potential & accelerate global development. @LancetGH #GlobalEyeHealth Commission reports on action needed now to deliver key 👁️ health services. https://t.co/aLNmwKVENB pic.twitter.com/u69JFGL2BY
— The Lancet (@TheLancet) February 17, 2021
Ocular MRI findings in patients with severe COVID-19
17 Feb, 2021 | 01:42h | UTCCommentaries: New COVID-19 side effect: MRI links severe infection to dangerous eye problems – Health Imaging AND MRI illuminates COVID-19’s negative impact on the eyes – AuntMinnie AND Windows of Infection: MRI Reveals COVID-19-Linked Eye Abnormalities – Diagnostic Imaging
Pediatric eye injuries by hydroalcoholic gel in the context of the Covid-19 Pandemic
12 Feb, 2021 | 02:12h | UTCCase series: Hand Sanitizer–Induced Ocular Injury: A COVID-19 Hazard in Children – JAMA Ophthalmology
Invited commentary: Unintended Consequences of Hand Sanitizer Use in the Coronavirus Disease 2019 Pandemic – JAMA Ophthalmology
State of the Art Review: Uveitis for the non-ophthalmologist
4 Feb, 2021 | 01:22h | UTCUveitis for the non-ophthalmologist – The BMJ (free for a limited period)
Systematic review: Worldwide incidence and prevalence of Neuromyelitis Optica
29 Jan, 2021 | 01:31h | UTCWorldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review – Neurology
Referral for disease-related visual impairment using retinal photograph-based deep learning: a proof-of-concept, model development study
22 Jan, 2021 | 08:16h | UTCInvited commentary: AI-automated referral for patients with visual impairment – The Lancet Digital Health
Commentary on Twitter
NEW Research: ‘Referral for disease-related visual impairment using #retinal photograph-based #DeepLearning: a proof-of-concept, model development study’. @snec_seri @dukenus @Astarhq @NTUsg @CUHKMedicine @SurajEye @UniHeidelberg @WestmeadInst @NUSMedicinehttps://t.co/iwCwYePLeu pic.twitter.com/Qksm3uPPVu
— The Lancet Digital Health (@LancetDigitalH) December 23, 2020